Suicidality - Articles - Page 2

Borderline Personality Disorder in the ED

January 7, 2022

Victor Hong, MD.
Clinical Assistant Professor, Department of Psychiatry, University of Michigan, Ann Arbor, MI.

Dr. Hong has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Patients with borderline personality disorder often show up in emergency rooms multiple times and can trigger frustration and countertransference reactions in clinicians. Dr. Hong tells us how to help these patients and their families develop the skills needed to manage their emotions.

Self-Harm in Adolescents With ADHD

October 18, 2021

Pavan Madan, MD.

Pavan Madan, MD. Dr. Madan has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

What is the relationship between ADHD and non-suicidal self-injury? This research update teases out an understanding of these and other common co-morbidities in a manner that suggests a practical approach to dealing with both problems in our child and adolescent patients.

The Effect of Age and Pubertal Stage on Mental Health in Gender-Incongruent Youths

May 20, 2021

John Raiss, MD.

John Raiss, MD. Dr. Raiss has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

When is the best time to begin gender affirming medical care (GAMC) with respect to addressing the mental health status of children and adolescents with Gender Dysphoric Disorder? Should we begin Hormone Replacement Therapy early or wait until the adolescent is older? This research update will help you grapple with this very public debate.

Intranasal Esketamine: New Hope for Suicidal Patients?

April 12, 2021

Daniel Carlat, MD

Victoria Hendrick, MD.

Editor in Chief, The Carlat Hospital Psychiatry Report. Chief, Inpatient Psychiatry, Olive View UCLA Medical Center.

Daniel Carlat, MD. Publisher, The Carlat Hospital Psychiatry Report. Dr. Hendrick and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Imagine a drug that resolves depression within hours in people at imminent risk of suicide. Esketamine may be such a drug — but is it a miracle cure? Here we look at the data and discuss the pros and cons of this new treatment.

Treating Pandemic-Associated Trauma in Children and Adolescents

March 12, 2021

Alan Steinberg, PhD and Naser Ahmadi, MD, PhD

Alan Steinberg, PhD Associate Director of the National Center for Child Traumatic Stress at UCLA.

Naser Ahmadi, MD, PhD Assistant Professor of Psychiatry at UCLA. Dr. Steinberg and Dr. Ahmadi have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In the age of COVID-19, clinicians need to assess for specific pandemic-related impacts on children and adolescents. UCLA has a new COVID-19 PTSD screen and they have also developed an effective intervention that targets and manages trauma triggers to address suicidality in children and adolescents for use in urgent settings.

Tips on the Doubts about Ketamine/Esketamine

August 19, 2020

Ketamine and esketamine have been shown to provide rapid relief of suicidality, however, many lingering doubts have been raised about these medicines. In a previous article from The Carlat Psychiatry Report, Nolan Williams, M.D., discusses the potential negative consequences of ketamine/esketamine treatment. Here are some of Dr. Williams’s tips:It might...

Study Ignites Controversy Over Trazodone and Suicide

May 7, 2020

Eugene Rubin, MD.

Eugene Rubin, MD. Dr. Rubin has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

When researchers at the Department of Veteran Affairs found a 61% increase in suicide attempts when veterans took trazodone vs. zolpidem for sleep, the story made headlines. We tease apart the strengths and weaknesses of this 350,000 subject study to see what the real risk is.

Getting Uncomfortable with Esketamine

January 13, 2020

Nolan Williams, MD

Nolan Williams, MD

Director of the Brain Stimulation Lab and Interventional Psychiatry Clinical Research Program; Assistant Professor of Psychiatry at Stanford University, CA. Dr. Williams has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The FDA approval of esketamine (Spravalto) left some unanswered questions, including suicide, addiction, withdrawal, neurotoxicity, and bladder inflammation. Nolan Williams addresses those risks and looks at where esketamine fits among other options like TMS and ECT. Dr. Williams directs the Interventional Psychiatry Clinical Research Program and Brain Stimulation Lab at Stanford University.

Varenicline and Bupropion: Soaring Again With EAGLES?

November 22, 2019

Nicholas Rosenlicht, MD.

Nicholas Rosenlicht, MD. Dr. Rosenlicht has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

This research update unpacks the details behind the landmark “EAGLES” trial (Evaluating Adverse Events in a Global Smoking Cessation Study), which led to the removal of the varenicline black box warning.

Update: Is Watching 13 Reasons Why Bad for Teens?

October 3, 2019

Kristen Gardner, PharmD

Kristen Gardner, PharmD Dr. Gardner has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In the March/April 2019 issue we unpacked a study on the popular Netflix series, 13 Reasons Why, which portrayed the bullying and suicide of a teenager. Although the program increased awareness of these issues, some clinicians argued that it glamorized suicide and would be detrimental to vulnerable viewers. In this issue we cover a follow up study examining the potential impact of the series on the suicide rate in teens.